Literature DB >> 19188565

Spectrum of illness: understanding biological patterns and relationships in chronic migraine.

Sheena K Aurora1.   

Abstract

Chronic migraine (CM) typically evolves from episodic migraine (EM) over months to years in susceptible individuals. Headaches increase in frequency over time, becoming less intense but more disabling and less responsive to treatment. The results of electrophysiologic and functional imaging studies indicate that CM is associated with abnormalities in the periaqueductal gray matter that may be progressive. In addition, CM is associated with a greater degree of impairment in cortical processing of sensory stimuli than EM, perhaps because of more pervasive or persistent cortical hyperexcitability. These findings fit with the model of migraine as a spectrum disorder, in which the clinical and pathophysiologic features of migraine may progress over time. This progression is postulated to result from changes in nociceptive thresholds and ensuing central sensitization caused by recurrent migraine in susceptible individuals, for whom risk factors have been described. Also, progression may lead to changes in baseline neurologic function between episodes of headache, evident in electrophysiologic and functional imaging studies and as an increase in depression, anxiety, nonhead pain, fatigue, gastrointestinal disorders, and other somatic complaints that may occur after years of EM. From the available research and migraine models, a concept of CM is emerging that identifies relatively permanent and pervasive central changes warranting novel, tolerable treatments. This model also implies that prevention of CM is an important goal in the management of EM, particularly for individuals who exhibit risk factors for chronic transformation.

Entities:  

Mesh:

Year:  2009        PMID: 19188565     DOI: 10.1212/WNL.0b013e31819749fd

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

Review 1.  [Chronic migraine].

Authors:  H C Diener; D Holle; D Müller; S Nägel; K Rabe
Journal:  Nervenarzt       Date:  2013-12       Impact factor: 1.214

2.  Fatigue, sleep-wake pattern, depressive and anxiety symptoms and body-mass index: analysis in a sample of episodic and chronic migraine patients.

Authors:  Cinzia Lucchesi; Filippo Baldacci; Martina Cafalli; Elisa Dini; Linda Giampietri; Gabriele Siciliano; Sara Gori
Journal:  Neurol Sci       Date:  2016-02-15       Impact factor: 3.307

3.  Identification of Allodynic Migraine Patients with the Turkish Version of the Allodynia Symptom Checklist: Reliability and Consistency Study.

Authors:  Osman Özgür Yalin; Derya Uludüz; Mehmet Ali Sungur; Hande Sart; Aynur Özge
Journal:  Noro Psikiyatr Ars       Date:  2016-04-15       Impact factor: 1.339

Review 4.  Mechanism of chronic migraine.

Authors:  Sheena K Aurora; Arun Kulthia; Patricia M Barrodale
Journal:  Curr Pain Headache Rep       Date:  2011-02

5.  TNF-α and Microglial Hormetic Involvement in Neurological Health & Migraine.

Authors:  Richard P Kraig; Heidi M Mitchell; Barbara Christie-Pope; Phillip E Kunkler; David M White; Ya-Ping Tang; George Langan
Journal:  Dose Response       Date:  2010-02-18       Impact factor: 2.658

6.  Poor Tolerance of Motor Cortex rTMS in Chronic Migraine.

Authors:  Wei-Peng Teo; Aravinda Kannan; Pei-Kee Loh; Effie Chew; Vijay Kumar Sharma; Yee-Cheun Chan
Journal:  J Clin Diagn Res       Date:  2014-09-20

Review 7.  Chronic migraine--classification, characteristics and treatment.

Authors:  Hans-Christoph Diener; David W Dodick; Peter J Goadsby; Richard B Lipton; Jes Olesen; Stephen D Silberstein
Journal:  Nat Rev Neurol       Date:  2012-02-14       Impact factor: 42.937

Review 8.  Neurobiology of migraine progression.

Authors:  Wanakorn Rattanawong; Alan Rapoport; Anan Srikiatkhachorn
Journal:  Neurobiol Pain       Date:  2022-06-09

9.  Polymorphism of the Glutamate Transporter Protein EAAT2 and Migraine Transformation into Chronic Daily Headache.

Authors:  Hae-Eun Shin; Soo-Jeong Han; Kwang-Soo Lee; Jeong-Wook Park
Journal:  J Clin Neurol       Date:  2011-09-29       Impact factor: 3.077

Review 10.  OnabotulinumtoxinA for chronic migraine: a critical appraisal.

Authors:  Rubesh Gooriah; Fayyaz Ahmed
Journal:  Ther Clin Risk Manag       Date:  2015-06-29       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.